S&P 500 slips on report Fed’s Waller leading race to replace Powell; tech shines
Investing.com - MDxHealth ADR (NASDAQ: MDXH) reported fourth quarter EPS of $-0.140, $0.05 better than the analyst estimate of $-0.190. Revenue for the quarter came in at $24.74M versus the consensus estimate of $22.9M.
Guidance
MDxHealth ADR sees FY 2025 revenue of $108.000M-$110.000M
MDxHealth ADR’s stock price closed at $1.83. It is down -8.500% in the last 3 months and down -51.200% in the last 12 months.
MDxHealth ADR saw 0 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See MDxHealth ADR’s stock price’s past reactions to earnings here.
According to InvestingPro, MDxHealth ADR’s Financial Health score is "good performance".
Check out MDxHealth ADR’s recent earnings performance, and MDxHealth ADR’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar